Navigation Links
Timing of HRT May Influence Heart Risks
Date:4/16/2008

Study found women with risk factors who took it early in menopause did not have diminished vessel function

WEDNESDAY, April 16 (HealthDay News) -- The timing of hormone therapy might determine its effect on a woman's heart.

Specifically, researchers have found that hormone replacement therapy (HRT) administered early in menopause to women with risk factors for heart disease did not diminish the function of the endothelial cells that line the inner walls of the arteries and might even improve it. Endothelial function is a way to measure early heart disease.

"Hormone therapy might not be as bad as was once thought," said Dr. Suzanne Steinbaum, director of Women and Heart Disease at Lenox Hill Hospital in New York City. "It might even be helpful in women with risk factors."

However, there isn't enough evidence to suggest that women should start taking HRT to lower their risk for heart disease, the authors emphasized.

The researchers, from Virginia Commonwealth University Medical Center in Richmond, presented their findings Wednesday at the American Heart Association's Arteriosclerosis, Thrombosis and Vascular Biology annual conference in Atlanta.

A section of the U.S. government-sponsored Women's Health Initiative (WHI), which was designed to look at health issues in postmenopausal women, was halted in 2002, when U.S. researchers found that hormone therapy led to an increased risk of adverse events that included heart attack, stroke, breast cancer and blood clots. The risk depended on whether the woman was taking estrogen alone or estrogen plus progestin, another female hormone.

Since that time, however, a more complex picture has emerged with various factors, including amount of hormone as well as timing, having an effect on risks and benefits of HRT.

Previous research indicated that HRT might have a negative effect on cardiovascular health in women who started therapy long after menopause, versus women taking it sooner after menopause.

Before the WHI, many women took HRT in the belief that it would reduce their risk for heart disease.

For this study, researchers used ultrasound to measure flow-mediated dilation (FMD) in the brachial artery in four groups of postmenopausal women (127 participants total).

FMD measures how well the endothelium functions. The brachial artery is the main artery in the arm.

"Endothelial dysfunction is often associated with risk factors," Steinbaum explained.

There were four groups in all: One comprised of women not on HRT, with no heart disease risk factors and about eight years postmenopausal; women not on HRT but who did have risk factors for coronary disease and a little over nine years postmenopausal; women taking estrogen alone, with risk factors and almost 12 years postmenopausal; and women taking estrogen plus progestin and 7.6 years postmenopausal.

Most women had started HRT about the time menopause started.

Women with risk factors who took HRT saw a slight improvement in FMD and, on the whole, there were no reductions in blood vessel function.

More information

Visit the Women's Health Initiative for more on hormone replacement therapy.



SOURCES: Suzanne Steinbaum, D.O., director, Women and Heart Disease, Lenox Hill Hospital, New York City; April 16, 2008, presentation, American Heart Association's Arteriosclerosis, Thrombosis and Vascular Biology annual conference, Atlanta


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. When It Comes to Pregnancy, Timing Is Everything
2. Communicating Clinical Trial Data: Timing Remains Key Challenge for Marketing Teams
3. Mylan Revises Timing of Its Financial Results Conference Call for the Quarter and Nine Months Ended Dec. 31, 2007, to 5 p.m. ET
4. Appropriate timing in the use of breast shields in children can further reduce MDCT radiation dose
5. AUDIO from Medialink and AXA Equitable: Timing Retirement Thinking
6. T cell immunity enhanced by timing of interleukin-7 therapy
7. eDiets.com(R) Updates Timing of Third Quarter 2007 Earnings Conference Call
8. Newly Launched Regence Foundation to Help Transform Health Care and Influence the Nationwide Health Care Debate
9. Genes Influence on Fears Changes Over Time
10. Neighborhood Influences Exercise Levels
11. Prostate size and other neglected factors influence prostate cancer treatment satisfaction
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Timing of HRT May Influence Heart Risks
(Date:4/25/2017)... , ... April 25, 2017 , ... ... have signed an agreement to be the preferred physical therapy provider for Derby ... returning them to Derby City CrossFit as quickly and effectively as possible, ProRehab’s ...
(Date:4/25/2017)... ... April 25, 2017 , ... The doctors at Wall ... who live with dental fear and require sedation to receive dental care. The doctors ... during various procedures, from hygienic cleanings to oral surgery, at their dental office in ...
(Date:4/25/2017)... (PRWEB) , ... April 25, 2017 , ... Back ... neck and back pain with a reputable physician in their area, announces the launch ... protects patient information for patients who are looking for reputable physicians to help them ...
(Date:4/25/2017)... ... April 25, 2017 , ... There is no better place in South ... special report in the May issue of Consumer Reports focused on heart health. ... results achieved during and after coronary bypass and aortic valve replacement procedures. , ...
(Date:4/24/2017)... ... , ... Michael Vick announced his retirement earlier this year from the NFL ... one pick in the 2001 NFL Draft, to the Atlanta Falcons, made four Pro ... career rushing yards by a quarterback (6,109) and the most rushing yards by a ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... April 19, 2017 The Global Effective ... to 2022 report has covered and analysed the potential of ... on market size, shares and growth factors. The report identifies ... and opportunities in the global market. ... Browse 152 Tables and Figures, 6 Major Company ...
(Date:4/19/2017)... 2017  SARES•REGIS Group leased the first of ... Conejo Spectrum Business Park in Thousand ... Inc. , a biopharmaceutical company developing meaningful therapies ... have been underserved by scientific innovation, with an ... autoimmune and infectious disease. Before commencement ...
(Date:4/18/2017)... -- Astute Medical, Inc., developer of biomarkers for better healthcare, ... the 2017 National Kidney Foundation (NKF) Spring Clinical ... 22. Physicians will present data on two biomarkers, ... acute kidney injury (AKI) during the management of patients ... Elevated levels of TIMP-2 and IGFBP-7 have been shown ...
Breaking Medicine Technology: